RecruitingNCT06976073

Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure

Sponsor

HJN Sverige AB/Neko Health

Enrollment

8,000 participants

Start Date

Feb 1, 2023

Study Type

OBSERVATIONAL

Conditions

Skin Cancer Peripheral Arterial Disease Diabetes Mellitus, Type 2 Diabetic Foot Cardiovascular Disease Risk

Summary

The goal of this clinical investigation is to explore a non-invasive technology for measuring the microcirculatory structure, composition and function in patients from a primary care population. The main aims are: 1. To evaluate the robustness of the technology for assessment of the molecular composition and structure of the skin tissue and microcirculatory function, on a prospective primary care population. 2. To evaluate the device and method on its capability to detect deficiencies in circulation, compared with existing reference systems with similar characteristics for patients with known cardiovascular disease risk and/or diabetes.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing non-invasive skin imaging technology to measure and map the composition and structure of skin (such as hydration, fat layers, and collagen), to see if these tools can be used in routine clinical care. **You may be eligible if...** - You are an adult patient at one of the participating clinics, or have been separately invited to take part - You can give informed consent **You may NOT be eligible if...** - You have cognitive impairment - You cannot understand the study information in Swedish or English - You have damaged, scarred, or broken skin in the area to be imaged - You have a severe illness or terminal disease - You are unable to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.